Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Prophylactic IgM-Enriched Immunoglobulin for the Management of Early-Onset Neonatal Sepsis in Very Low Birth Weight Preterm Neonates; A Randomized Controlled Trial

NCT04041765 is registered in ClinicalTrials.gov with Fakultas Kedokteran Universitas Indonesia as lead sponsor.

NCT NCT04041765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04041765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Prophylactic IgM-Enriched Immunoglobulin for the Management of Early-Onset Neonatal Sepsis in Very Low Birth Weight Preterm Neonates; A Randomized Controlled Trial
Lead sponsor
Fakultas Kedokteran Universitas Indonesia
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2019
Completion date
August 31, 2020
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infant, newborn, disease, inflammation, neonatal sepsis, early-onset, very low birth weight infant